Hypertrophic cardiomyopathy treatment strategy: Difference between revisions
Jump to navigation
Jump to search
(Created page with "{{Hypertrophic cardiomyopathy}} {{CMG}}; {{AOEIC}} {{LG}} ==Treatment strategy based on clinical presentation== Image:HCM treatment strategy.JPG <br clear="left"/> Adapted f...") |
|
(No difference)
| |
Latest revision as of 16:26, 11 February 2012
|
Hypertrophic Cardiomyopathy Microchapters |
|
Differentiating Hypertrophic Cardiomyopathy from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hypertrophic cardiomyopathy treatment strategy On the Web |
|
Directions to Hospitals Treating Hypertrophic cardiomyopathy |
|
Risk calculators and risk factors for Hypertrophic cardiomyopathy treatment strategy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Lakshmi Gopalakrishnan, M.B.B.S. [2]
Treatment strategy based on clinical presentation
Adapted from ESC Clinical Practice Guidelines[1] and The management of hypertrophic cardiomyopathy[2].
References
- ↑ Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE; et al. (2003). "American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines". Eur Heart J. 24 (21): 1965–91. PMID 14585256.
- ↑ Spirito P, Seidman CE, McKenna WJ, Maron BJ (1997). "The management of hypertrophic cardiomyopathy". N Engl J Med. 336 (11): 775–85. doi:10.1056/NEJM199703133361107. PMID 9052657.